V023-1225 Screening compound: N-{4-[(2,3-DIMETHOXYPHENYL)METHYL]-2-METHYL-3-OXO-2,3,4,5-TETRAHYDRO-1,4-BENZOXAZEPIN-7-YL}CYCLOPROPANECARBOXAMIDE

V023-1225 Screening compound: N-{4-[(2,3-DIMETHOXYPHENYL)METHYL]-2-METHYL-3-OXO-2,3,4,5-TETRAHYDRO-1,4-BENZOXAZEPIN-7-YL}CYCLOPROPANECARBOXAMIDE
V023-1225 Screening compound: N-{4-[(2,3-DIMETHOXYPHENYL)METHYL]-2-METHYL-3-OXO-2,3,4,5-TETRAHYDRO-1,4-BENZOXAZEPIN-7-YL}CYCLOPROPANECARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-1225
N-{4-[(2,3-DIMETHOXYPHENYL)METHYL]-2-METHYL-3-OXO-2,3,4,5-TETRAHYDRO-1,4-BENZOXAZEPIN-7-YL}CYCLOPROPANECARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-1225

Molecular Formula

C23H26N2O5 (C23 H26 N2 O5)

Compound Name

N-{4-[(2,3-DIMETHOXYPHENYL)METHYL]-2-METHYL-3-OXO-2,3,4,5-TETRAHYDRO-1,4-BENZOXAZEPIN-7-YL}CYCLOPROPANECARBOXAMIDE

IUPAC name

N-{4-[(23-dimethoxyphenyl)methyl]-2-methyl-3-oxo-2345-tetrahydro-14-benzoxazepin-7-yl}cyclopropanecarboxamide

SMILES

CC(C(N(Cc(cccc1OC)c1OC)C1)=O)Oc(cc2)c1cc2NC(C1CC1)=O

InChI

InChI=1S/C23H26N2O5/c1-14-23(27)25(12-16-5-4-6-20(28-2)21(16)29-3)13-17-11-18(9-10-19(17)30-14)24-22(26)15-7-8-15/h4-6,9-11,14-15H,7-8,12-13H2,1-3H3,(H,24,26)/t14-/m0/s1

InChI Key

YOVBGEKBJNYEHD-AWEZNQCLSA-N

MDL Number (MFCD)

MFCD19854521

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

410.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.223

Distribution Coefficient, logD

3.223

Water Solubility, LogSw

-3.48

Polar Surface Area

63.543

Acid Dissociation Constant (pKa)

12.31

Base Dissociation Constant (pKb)

6.57

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.10

V023-1225 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V023-1225 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-1225?
Check Price and Availability of V023-1225, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-1225 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-1225
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-1225
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-1225 available by request